| Title |
A clinical and safety review of paracetamol and ibuprofen in children
|
|---|---|
| Published in |
Inflammopharmacology, January 2017
|
| DOI | 10.1007/s10787-016-0302-3 |
| Pubmed ID | |
| Authors |
Dipak J. Kanabar |
| Abstract |
The antipyretic analgesics, paracetamol, and non-steroidal anti-inflammatory agents NSAIDs are one of the most widely used classes of medications in children. The aim of this review is to determine if there are any clinically relevant differences in safety between ibuprofen and paracetamol that may recommend one agent over the other in the management of fever and discomfort in children older than 3 months of age. |
X Demographics
The data shown below were collected from the profiles of 44 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 14 | 32% |
| United States | 2 | 5% |
| Canada | 1 | 2% |
| Serbia | 1 | 2% |
| Unknown | 26 | 59% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 44 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 264 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 264 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 56 | 21% |
| Student > Master | 23 | 9% |
| Other | 17 | 6% |
| Researcher | 15 | 6% |
| Student > Ph. D. Student | 13 | 5% |
| Other | 32 | 12% |
| Unknown | 108 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 56 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 13% |
| Nursing and Health Professions | 16 | 6% |
| Agricultural and Biological Sciences | 10 | 4% |
| Biochemistry, Genetics and Molecular Biology | 10 | 4% |
| Other | 27 | 10% |
| Unknown | 111 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 June 2023.
All research outputs
#870,896
of 25,651,057 outputs
Outputs from Inflammopharmacology
#28
of 686 outputs
Outputs of similar age
#18,092
of 423,254 outputs
Outputs of similar age from Inflammopharmacology
#1
of 10 outputs
Altmetric has tracked 25,651,057 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 686 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 423,254 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them